These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23375618)

  • 21. Beta blockers therapy is associated with improved left ventricular systolic function and sustained exercise capacity in elderly patients with heart failure. CIBIS-ELD sub-study.
    Dekleva M; Düngen HD; Gelbrich G; Incrot S; Suzic Lazic J; Pavlovic Kleut M; Tahirovic E; Waagstein F
    Aging Clin Exp Res; 2012 Dec; 24(6):675-81. PubMed ID: 23147689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effects of carvedilol vs bisoprolol for severe congestive heart failure.
    Konishi M; Haraguchi G; Kimura S; Inagaki H; Kawabata M; Hachiya H; Hirao K; Isobe M
    Circ J; 2010 Jun; 74(6):1127-34. PubMed ID: 20354334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).
    Böhm M; Maack C; Wehrlen-Grandjean M; Erdmann E
    Z Kardiol; 2003 Aug; 92(8):668-76. PubMed ID: 12955414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant?
    Agostoni P; Contini M; Cattadori G; Apostolo A; Sciomer S; Bussotti M; Palermo P; Fiorentini C
    Eur J Heart Fail; 2007 Aug; 9(8):827-33. PubMed ID: 17561440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.
    Lancet; 1999 Jan; 353(9146):9-13. PubMed ID: 10023943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-blockers in heart failure: how far have we progressed?
    Adams KF
    Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):7-15. PubMed ID: 19667603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.
    Chin BS; Gibbs CR; Blann AD; Lip GY
    Clin Sci (Lond); 2003 Oct; 105(4):507-12. PubMed ID: 12841846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design of the cardiac insufficiency bisoprolol study II (CIBIS II). The CIBIS II Scientific Committee.
    Fundam Clin Pharmacol; 1997; 11(2):138-42. PubMed ID: 9107560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The comparative effects of long-term carvedilol versus bisoprolol therapy on QT dispersion in patients with chronic heart failure.
    Aygul N; Ozdemir K; Duzenli MA; Aygul MU
    Cardiology; 2009; 112(3):168-73. PubMed ID: 18654081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the FEW16 questionnaire for the assessment of physical well-being in patients with heart failure with reduced ejection fraction: results from the CIBIS-ELD study.
    Tahirović E; Lashki DJ; Trippel TD; Tscholl V; Fritschka M; Musial-Bright L; Busjahn A; Kolip P; Störk S; Rauchfuß M; Inkrot S; Lainscak M; Apostolović S; Vesković J; Lončar G; Doehner W; Zelenak C; Düngen HD
    ESC Heart Fail; 2015 Sep; 2(3):194-203. PubMed ID: 27708856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of statin therapy on clinical outcomes in chronic heart failure patients according to beta-blocker use: results of CIBIS II.
    Krum H; Bailey M; Meyer W; Verkenne P; Dargie H; Lechat P; Anker S
    Cardiology; 2007; 108(1):28-34. PubMed ID: 16960445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerability of beta-blocker initiation and titration with bisoprolol and carvedilol in congestive heart failure -- a randomized comparison.
    Galatius S; Gustafsson F; Atar D; Hildebrandt PR
    Cardiology; 2004; 102(3):160-5. PubMed ID: 15334027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisoprolol: a review of its use in chronic heart failure.
    McGavin JK; Keating GM
    Drugs; 2002; 62(18):2677-96. PubMed ID: 12466013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-blockade treatment in heart failure: the cardiac insufficiency bisoprolol study (CIBIS) project. CIBIS Committees and Investigators. Cardiac Insufficiency Bisoprolol Study.
    Lechat P
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S158-63. PubMed ID: 11534531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sudden cardiac death risk factors in patients with heart failure treated with carvedilol.
    Nessler J; Nessler B; Kitliński M; Libionka A; Kubinyi A; Konduracka E; Piwowarska W
    Kardiol Pol; 2007 Dec; 65(12):1417-22; discussion 1423-4. PubMed ID: 18181053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting response to carvedilol for the treatment of heart failure: a multivariate retrospective analysis.
    Schleman KA; Lindenfeld JA; Lowes BD; Bristow MR; Ferguson D; Wolfel EE; Abraham WT; Zisman LS
    J Card Fail; 2001 Mar; 7(1):4-12. PubMed ID: 11264544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carvedilol produces sustained long-term benefits: follow-up at 12 years.
    MacGregor JF; Wachter SB; Munger M; Stoddard G; Bristow MR; Gilbert EM
    Congest Heart Fail; 2009; 15(1):5-8. PubMed ID: 19187400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The early anti-oxidant effect of carvedilol predicts the clinical course in congestive heart failure patients.
    Goldhammer E; Maor I; Shnitzer S; Lanir A; Abinader EG
    J Cardiovasc Med (Hagerstown); 2007 Jun; 8(6):453-6. PubMed ID: 17502762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ivabradine improves all aspects of quality of life assessed with the 36-item short form health survey in subjects with chronic ischemic heart disease compared with beta-blockers.
    Riccioni G; Prencipe G; Benvenuto A; Masciocco L; Ventra S; Rizzo U; Russi C; Speziale G
    Pharmacology; 2013; 91(1-2):35-8. PubMed ID: 23146926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.